![]() ![]() ![]() Affected individuals may experience recurrent respiratory infections. Such symptoms include cough, fatigue, shortness of breath (dyspnea), coughing up of blood (hemoptysis), excessive mucus (sputum) production, fever, night sweats, loss of appetite, and unintended weight loss. The symptoms are usually nonspecific and similar to the symptoms seen in other lung or respiratory infections. Chronic lung infection is the most common complication affecting approximately 94% of individuals. The reason for this variability is not fully understood. The symptoms and severity can vary greatly from one person to another. In other cases, the infection can become chronic requiring ongoing treatment. Less severe infections may not require treatment. NTM lung disease most commonly affects people with an underlying lung disease such as chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, and alpha-1-antitrypsin disease, but individuals with no prior history of lung disease can also be affected. Most evidence indicates that these infections are not transmitted from one person to another, but are acquired from the environment. #RAYS LEARNING REPORT ASSISTANT FOR MAC SKIN#Less often, NTM infection can cause skin or soft tissue infections or infection and inflammation of the lymph nodes (lymphadenitis). The most common symptoms include a persistent cough, fatigue, weight loss, night sweats, and occasionally shortness of breath (dyspnea) and coughing up of blood (hemoptysis). In NTM disorders, the severity of infection and the disease course can vary greatly from one person to another. These disorders also exclude Mycobacterium leprae, the mycobacterium that causes leprosy. The term ‘nontuberculous’ is used to differentiate these disorders from the mycobacterium that cause tuberculosis (i.e. These germs are found in the water and soil and are common throughout the environment as a whole. Nontuberculous mycobacterial (NTM) lung disease is a general term for a group of disorders characterized by exposure to specific bacterial germs known as mycobacteria. 5 Myths About Orphan Drugs and the Orphan Drug Act.Information on Clinical Trials and Research Studies. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |